86 related articles for article (PubMed ID: 12513790)
1. [Comparative study on activated immunocytes of human bone marrow and peripheral blood by cytokines].
Huang WR; Zhang BL; Jin HJ; Gao CJ; Da WM; Wang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):222-5. PubMed ID: 12513790
[TBL] [Abstract][Full Text] [Related]
2. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
[TBL] [Abstract][Full Text] [Related]
3. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
[TBL] [Abstract][Full Text] [Related]
4. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
5. Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity.
Doskali M; Tanaka Y; Ohira M; Ishiyama K; Tashiro H; Chayama K; Ohdan H
J Immunother; 2011 Mar; 34(2):129-38. PubMed ID: 21304407
[TBL] [Abstract][Full Text] [Related]
6. [Study on induction of dendritic cells from myeloid leukemia cell lines and their antitumor immune function].
Luo YP; Li YG; Cai DC; Ren H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):229-35. PubMed ID: 12513792
[TBL] [Abstract][Full Text] [Related]
7. [Co-stimulation of multiple activating factors on proliferation and phenotype of T lymphocytes in peripheral blood in vitro].
Liu JQ; Zhu Y; Chen FX; Zhang NZ; Lv XT; Zhou ZH; Zhang J; Zhang S; Tao ZZ; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):367-70. PubMed ID: 22482405
[TBL] [Abstract][Full Text] [Related]
8. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
Zhu BQ; Ju SW; Shu YQ
Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients.
Cortelezzi A; Sarina B; Cattaneo C; Pomati M; Silvestris I; Soligo D; Calori R; Di Stefano M; Hu C; Monza M; Radelli L; Maiolo AT
Leukemia; 1996 Jul; 10(7):1181-9. PubMed ID: 8684000
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study on the lysis of leukemia cells by IL-2 activated bone marrow and cord blood].
Shi X; Yu Z; Ma R
Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):417-21. PubMed ID: 15625848
[TBL] [Abstract][Full Text] [Related]
11. [Morphology and Immunophenotype Study of Bone Marrow Mononuclear Cells after Activated by Different Cytokines In Vitro].
Huang WR; Zhang BL; Jin HJ; Gao CJ; Da WM; Shi ZJ; Zhang ZQ; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Sep; 9(3):197-201. PubMed ID: 12578588
[TBL] [Abstract][Full Text] [Related]
12. [Activation and Cytotoxicity of Bone Marrow Immunocytes by Using Various Cytokines].
Huang WR; Gao CJ; Zhang BL; Jin HJ; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Mar; 9(1):48-51. PubMed ID: 12578645
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and cell cycle analysis of human peripheral blood mononuclear cells activated with interleukin-2 and/or OKT3.
Platts KE; Lawry J; Hancock BW; Rees RC
Exp Cell Res; 1993 Sep; 208(1):154-60. PubMed ID: 8359215
[TBL] [Abstract][Full Text] [Related]
14. [Synergic effect of heparan sulfate and cytokines on in vitro growth of human umbilical cord blood hematopoietic cells].
Wen Z; Dai Y; Li J; Tang Y
Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):531-3. PubMed ID: 12482351
[TBL] [Abstract][Full Text] [Related]
15. Effects of CD3McAb and rhIL-2 activated bone marrow on the killing and purging of leukemia cells.
Wei XC; Yang DD; Han XR; Zhao YA; Li YC; Zhang LJ; Wang JJ
Genet Mol Res; 2015 Dec; 14(4):18287-92. PubMed ID: 26782476
[TBL] [Abstract][Full Text] [Related]
16. [Morphological and functional characteristics of lymphokine-activated killer cells generated from the mononuclear cells of human peripheral blood].
Lebedinskaia OV; Khalturina EO; Akhmatova NK; Shubina IZh; Leonova OG; Popenko VI; Melekhin SV; Kiselevskiĭ MV
Morfologiia; 2005; 127(1):36-40. PubMed ID: 16080346
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells.
Joshi SS; Babushkina-Patz NN; Verbik DJ; Gross TG; Tarantolo SR; Kuszynski CA; Pirruccello SJ; Bishop MR; Kessinger A
Int J Oncol; 1998 Oct; 13(4):791-9. PubMed ID: 9735410
[TBL] [Abstract][Full Text] [Related]
18. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro.
Kelly-Rogers J; Madrigal-Estebas L; O'Connor T; Doherty DG
Hum Immunol; 2006 Nov; 67(11):863-73. PubMed ID: 17145366
[TBL] [Abstract][Full Text] [Related]
19. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
[TBL] [Abstract][Full Text] [Related]
20. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients.
Fujimiya Y; Wagner RJ; Groveman S; Sielaff K; Kohsaka T; Nakayama M
Ther Immunol; 1995 Feb; 2(1):15-22. PubMed ID: 7553067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
